MS
Maheshwar Suryapet
About Maheshwar Suryapet
Maheshwar Suryapet has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Mekong Pharmaceuticals Private Limited and Greenovel Life Sciences Private Limited. Formerly with 2 companies, such as Apisun Exim Private Limited and Ennoble Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Mekong Pharmaceuticals Private Limited
U74999TG2018PTC125052
|
Director | 12 Jun 2018 | 2018 | Active |
Greenovel Life Sciences Private Limited
U74999TG2020PTC144262
|
Director | 26 Sep 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Apisun Exim Private Limited
U74900TG2013PTC087889
|
Director | 26 Aug 2019 | 2013 | Active |
Ennoble Life Sciences Private Limited
U24299TG2022PTC160436
|
Director | 09 Mar 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maheshwar Suryapet
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maheshwar Suryapet
Maheshwar Suryapet has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Mekong Pharmaceuticals Private Limited and Greenovel Life Sciences Private Limited. Formerly with 2 companies, such as Apisun Exim Private Limited and Ennoble Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Maheshwar Suryapet is associated with 2 companies as Director.
Maheshwar Suryapet has expertise in General Business.
Maheshwar Suryapet has 8 years in corporate governance.